Flourishing trade activity in life science industry

The life science industry has had a handful of business trades in the year's first month and a half. There's a high level of activity, industry sources tell MedWatch.

Photo: Colourbox

In the last two months or so, business trade activity has flourished in the life science industry with a series of Danish companies getting new ownership.

Gorrissen Federspiel Partner and Chairman of the Board Niels Bang reports that things are busy in the life science business area. He highlights that the high level of activity from the second half-year of 2020 has carried over into the new year.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Rumored GN purchase unlikely but not impossible, say analysts

A low value assessment, a high structural value, and no dominant shareholders make GN Group a reasonable investment case for international private equity firms and industrial players. But just how likely is it? Analysts reveal their best bets for what a GN acquisition could look like.

New CFO wants to shake things up at WSA

A mere month into her new job, Marianne Wiinholt, WS Audiology’s fifth chief financial officer since the firm was established through a merger in 2019, is heralding great structural changes.

Further reading

Related articles

Latest news

See all jobs